Neurocrine Biosciences Launches Interactive Educational Resources to Support Clinical Learning in Classic Congenital Adrenal Hyperplasia

Eiry W. Roberts, M.D., Chief Medical Officer, Neurocrine Biosciences

“Whether they care for congenital adrenal hyperplasia patients routinely or encounter the condition only occasionally, these educational resources are designed to help clinicians feel equipped to recognize, manage and navigate the challenges of this lifelong disease”

Eiry W. Roberts, M.D., Chief Medical Officer, Neurocrine Biosciences

“BootCAHmp and DiscoverCAH were developed with leading experts to provide complementary learning experiences combining foundational scientific education with real-world clinical scenarios, helping healthcare providers deepen their understanding of this complex disease.”

Maya Lodish, M.D., M.H.Sc., Professor of Pediatrics and Division Chief of Pediatric Endocrinology, University of California, San Francisco

“This hands-on course uses real patient cases to illustrate the impact of classic congenital adrenal hyperplasia on patients while helping clinicians build a strong foundation for managing this complex condition”

Maya Lodish, M.D., M.H.Sc., Professor of Pediatrics and Division Chief of Pediatric Endocrinology, University of California, San Francisco

“It is a practical and comprehensive way to expand clinical knowledge of a disease that healthcare providers may not frequently encounter.”

Vivian H. Lin, M.D., Executive Medical Director, Medical Affairs, Neurocrine Biosciences

“Classic congenital adrenal hyperplasia presents differently from patient to patient and clinicians may not have many opportunities to gain experience managing a variety of cases”

Vivian H. Lin, M.D., Executive Medical Director, Medical Affairs, Neurocrine Biosciences

“DiscoverCAH gives healthcare professionals a chance to learn while working through realistic management scenarios without any clinical risk to patients.”